P. Brooks

Insulin-like Growth Factor Binding Protein-4 Differentially Inhibits Growth Factor-induced Angiogenesis*

C. Rosen, R. Friesel, A. Akalu, 2011, The Journal of Biological Chemistry.

BAY 43-9006 (sorafenib-BAY) alters proliferation pathways and mutant specific-PCR (MS-PCR) improves detection of BRAF mutations in metastatic melanoma (MM)

D. Polsky, H. Yee, I. Osman, 2007 .

Disease‐modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and penicillamine

P. Conaghan, L. Girgis, P. Brooks, 1993, Current Opinion in Rheumatology.

A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis.

P. Brooks, J. Snowden, J. Biggs, 1999, Arthritis and rheumatism.

Stem cell transplantation for autoimmune diseases

P. Brooks, J. Moore, P. Brooks, 2009, Springer Seminars in Immunopathology.

Disease-modifying antirheumatic drugs, including methotrexate, gold, antimalarials, and D-penicillamine.

P. Brooks, P. Conaghan, P G Conaghan, 1995, Current opinion in rheumatology.